SCHEMBL2116454

SCHEMBL2116454

CCC(C)c1ccc2ccccc2c1S

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.44
ALDH1A1 P00352 4/20 0.38
CYP2A6 P11509 2/20 0.38
HSD17B10 Q99714 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
HPRT1 P00492 1/20 0.35
CYP1A2 P05177 2/20 0.34
HTR2A P28223 2/20 0.34
HTR2C P28335 1/20 0.34
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
RCE1 Q9Y256 1/20 0.33
HIF1A Q16665 1/20 0.33
CYP1B1 Q16678 1/20 0.33
TLR8 Q9NR97 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11374363 0.82 TSHR (0.53) TSHRRCE1
SCHEMBL2116695 0.81 ALDH1A1 (0.44) TSHRALDH1A1CYP2A6HSD17B10TDP1
SCHEMBL6546925 0.80 TSHR (0.48) TSHRALDH1A1CYP2A6HSD17B10TDP1
SCHEMBL6546616 0.80 TSHR (0.46) TSHRALDH1A1CYP2A6HSD17B10TDP1
SCHEMBL8172019 0.79 TSHR (0.44) TSHRALDH1A1CYP2A6HSD17B10TDP1
SCHEMBL2116452 0.79 TSHR (0.44) TSHRALDH1A1CYP2A6HSD17B10TDP1
Hydrogen Sulfide SCHEMBL28183437 0.79 TSHR (0.44) TSHRALDH1A1CYP2A6HSD17B10TDP1
SCHEMBL9953195 0.79 TSHR (0.44) TSHRALDH1A1CYP2A6HSD17B10TDP1
SCHEMBL9953200 0.79 TSHR (0.44) TSHRALDH1A1CYP2A6HSD17B10TDP1
SCHEMBL2127427 0.77 TSHR (0.55) TSHRALDH1A1CYP1A2KMT2ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130123326-A1 ALLOSTERIC BINDING COMPOUNDS REGION MIDTJYLLAND (DK) 2013-05-16 US claimed
US-20120095048-A1 ALLOSTERIC BINDING COMPOUNDS REGION MIDT JYLLAND (DK) 2012-04-19 US claimed
EP-2398760-A1 ALLOSTERIC BINDING COMPOUNDS Aarhus Universitet (DK) 2011-12-28 EP claimed
WO-2010094289-A1 ALLOSTERIC BINDING COMPOUNDS AARHUS UNIVERSITET (DK) 2010-08-26 WO claimed
US-20130123326-A1 ALLOSTERIC BINDING COMPOUNDS REGION MIDTJYLLAND (DK) 2013-05-16 US disclosed
US-20120095048-A1 ALLOSTERIC BINDING COMPOUNDS REGION MIDT JYLLAND (DK) 2012-04-19 US disclosed
EP-2398760-A1 ALLOSTERIC BINDING COMPOUNDS Aarhus Universitet (DK) 2011-12-28 EP disclosed
WO-2010094289-A1 ALLOSTERIC BINDING COMPOUNDS AARHUS UNIVERSITET (DK) 2010-08-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095048-A1 ALLOSTERIC BINDING COMPOUNDS GRIN2C, GRM2, GRIN2B TSHR 534/4885ALDH1A1 3676/4885CYP2A6 990/4885
US-20130123326-A1 ALLOSTERIC BINDING COMPOUNDS GRIN2C, GRM2, GRIN2B TSHR 534/4885ALDH1A1 3676/4885CYP2A6 990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.